![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NDUFA12 |
Gene summary for NDUFA12 |
![]() |
Gene information | Species | Human | Gene symbol | NDUFA12 | Gene ID | 55967 |
Gene name | NADH:ubiquinone oxidoreductase subunit A12 | |
Gene Alias | B17.2 | |
Cytomap | 12q22 | |
Gene Type | protein-coding | GO ID | GO:0006091 | UniProtAcc | Q9UI09 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55967 | NDUFA12 | CA_HPV_1 | Human | Cervix | CC | 1.55e-08 | -1.82e-01 | 0.0264 |
55967 | NDUFA12 | CCI_1 | Human | Cervix | CC | 2.89e-05 | -5.79e-01 | 0.528 |
55967 | NDUFA12 | CCI_3 | Human | Cervix | CC | 1.74e-04 | -4.86e-01 | 0.516 |
55967 | NDUFA12 | CCII_1 | Human | Cervix | CC | 9.38e-17 | -6.56e-01 | 0.3249 |
55967 | NDUFA12 | L1 | Human | Cervix | CC | 1.37e-04 | -3.01e-01 | 0.0802 |
55967 | NDUFA12 | HTA11_2487_2000001011 | Human | Colorectum | SER | 3.01e-06 | 4.38e-01 | -0.1808 |
55967 | NDUFA12 | HTA11_1938_2000001011 | Human | Colorectum | AD | 6.37e-14 | 7.16e-01 | -0.0811 |
55967 | NDUFA12 | HTA11_347_2000001011 | Human | Colorectum | AD | 5.46e-13 | 4.52e-01 | -0.1954 |
55967 | NDUFA12 | HTA11_3361_2000001011 | Human | Colorectum | AD | 1.66e-02 | 4.46e-01 | -0.1207 |
55967 | NDUFA12 | HTA11_83_2000001011 | Human | Colorectum | SER | 9.82e-03 | 3.44e-01 | -0.1526 |
55967 | NDUFA12 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.58e-05 | 3.65e-01 | -0.1464 |
55967 | NDUFA12 | HTA11_1391_2000001011 | Human | Colorectum | AD | 2.10e-14 | 7.51e-01 | -0.059 |
55967 | NDUFA12 | HTA11_2992_2000001011 | Human | Colorectum | SER | 6.91e-07 | 7.91e-01 | -0.1706 |
55967 | NDUFA12 | HTA11_5212_2000001011 | Human | Colorectum | AD | 2.36e-11 | 8.29e-01 | -0.2061 |
55967 | NDUFA12 | HTA11_546_2000001011 | Human | Colorectum | AD | 1.47e-03 | 3.93e-01 | -0.0842 |
55967 | NDUFA12 | HTA11_7862_2000001011 | Human | Colorectum | AD | 3.99e-03 | 4.04e-01 | -0.0179 |
55967 | NDUFA12 | HTA11_866_3004761011 | Human | Colorectum | AD | 2.10e-07 | 3.23e-01 | 0.096 |
55967 | NDUFA12 | HTA11_4255_2000001011 | Human | Colorectum | SER | 3.19e-02 | 4.65e-01 | 0.0446 |
55967 | NDUFA12 | HTA11_7663_2000001011 | Human | Colorectum | SER | 1.12e-03 | 5.34e-01 | 0.0131 |
55967 | NDUFA12 | HTA11_6801_2000001011 | Human | Colorectum | SER | 2.99e-05 | 6.14e-01 | 0.0171 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004603410 | Cervix | CC | ATP metabolic process | 90/2311 | 277/18723 | 7.90e-19 | 2.36e-15 | 90 |
GO:000611910 | Cervix | CC | oxidative phosphorylation | 55/2311 | 141/18723 | 7.12e-16 | 1.42e-12 | 55 |
GO:00090609 | Cervix | CC | aerobic respiration | 60/2311 | 189/18723 | 1.59e-12 | 6.36e-10 | 60 |
GO:00427739 | Cervix | CC | ATP synthesis coupled electron transport | 38/2311 | 95/18723 | 8.45e-12 | 2.66e-09 | 38 |
GO:00427759 | Cervix | CC | mitochondrial ATP synthesis coupled electron transport | 38/2311 | 95/18723 | 8.45e-12 | 2.66e-09 | 38 |
GO:00229049 | Cervix | CC | respiratory electron transport chain | 42/2311 | 114/18723 | 1.67e-11 | 4.77e-09 | 42 |
GO:00453339 | Cervix | CC | cellular respiration | 66/2311 | 230/18723 | 2.07e-11 | 5.39e-09 | 66 |
GO:00229009 | Cervix | CC | electron transport chain | 53/2311 | 175/18723 | 2.23e-10 | 3.43e-08 | 53 |
GO:000697910 | Cervix | CC | response to oxidative stress | 102/2311 | 446/18723 | 2.99e-10 | 4.36e-08 | 102 |
GO:00060919 | Cervix | CC | generation of precursor metabolites and energy | 105/2311 | 490/18723 | 7.40e-09 | 6.61e-07 | 105 |
GO:00159809 | Cervix | CC | energy derivation by oxidation of organic compounds | 74/2311 | 318/18723 | 3.83e-08 | 2.53e-06 | 74 |
GO:00102579 | Cervix | CC | NADH dehydrogenase complex assembly | 22/2311 | 57/18723 | 4.28e-07 | 1.67e-05 | 22 |
GO:00329819 | Cervix | CC | mitochondrial respiratory chain complex I assembly | 22/2311 | 57/18723 | 4.28e-07 | 1.67e-05 | 22 |
GO:00331089 | Cervix | CC | mitochondrial respiratory chain complex assembly | 26/2311 | 93/18723 | 3.97e-05 | 6.18e-04 | 26 |
GO:0046034 | Colorectum | AD | ATP metabolic process | 142/3918 | 277/18723 | 2.64e-29 | 8.26e-26 | 142 |
GO:0006091 | Colorectum | AD | generation of precursor metabolites and energy | 209/3918 | 490/18723 | 3.17e-28 | 6.61e-25 | 209 |
GO:0009060 | Colorectum | AD | aerobic respiration | 108/3918 | 189/18723 | 9.14e-28 | 1.43e-24 | 108 |
GO:0045333 | Colorectum | AD | cellular respiration | 119/3918 | 230/18723 | 3.21e-25 | 4.02e-22 | 119 |
GO:0006119 | Colorectum | AD | oxidative phosphorylation | 83/3918 | 141/18723 | 7.95e-23 | 8.30e-20 | 83 |
GO:0015980 | Colorectum | AD | energy derivation by oxidation of organic compounds | 143/3918 | 318/18723 | 2.78e-22 | 2.49e-19 | 143 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0520820 | Cervix | CC | Chemical carcinogenesis - reactive oxygen species | 92/1267 | 223/8465 | 4.71e-22 | 5.09e-20 | 3.01e-20 | 92 |
hsa0501220 | Cervix | CC | Parkinson disease | 102/1267 | 266/8465 | 1.81e-21 | 1.47e-19 | 8.66e-20 | 102 |
hsa0019018 | Cervix | CC | Oxidative phosphorylation | 64/1267 | 134/8465 | 1.25e-19 | 8.07e-18 | 4.77e-18 | 64 |
hsa0502018 | Cervix | CC | Prion disease | 98/1267 | 273/8465 | 2.64e-18 | 1.42e-16 | 8.42e-17 | 98 |
hsa0541520 | Cervix | CC | Diabetic cardiomyopathy | 76/1267 | 203/8465 | 1.40e-15 | 6.46e-14 | 3.82e-14 | 76 |
hsa0501018 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa0501618 | Cervix | CC | Huntington disease | 94/1267 | 306/8465 | 8.49e-13 | 3.06e-11 | 1.81e-11 | 94 |
hsa0502218 | Cervix | CC | Pathways of neurodegeneration - multiple diseases | 128/1267 | 476/8465 | 2.87e-12 | 9.29e-11 | 5.50e-11 | 128 |
hsa0493218 | Cervix | CC | Non-alcoholic fatty liver disease | 58/1267 | 155/8465 | 3.58e-12 | 1.05e-10 | 6.23e-11 | 58 |
hsa0471420 | Cervix | CC | Thermogenesis | 76/1267 | 232/8465 | 4.29e-12 | 1.16e-10 | 6.85e-11 | 76 |
hsa0501418 | Cervix | CC | Amyotrophic lateral sclerosis | 103/1267 | 364/8465 | 1.79e-11 | 4.47e-10 | 2.64e-10 | 103 |
hsa0472318 | Cervix | CC | Retrograde endocannabinoid signaling | 42/1267 | 148/8465 | 1.79e-05 | 1.42e-04 | 8.40e-05 | 42 |
hsa05208110 | Cervix | CC | Chemical carcinogenesis - reactive oxygen species | 92/1267 | 223/8465 | 4.71e-22 | 5.09e-20 | 3.01e-20 | 92 |
hsa05012110 | Cervix | CC | Parkinson disease | 102/1267 | 266/8465 | 1.81e-21 | 1.47e-19 | 8.66e-20 | 102 |
hsa0019019 | Cervix | CC | Oxidative phosphorylation | 64/1267 | 134/8465 | 1.25e-19 | 8.07e-18 | 4.77e-18 | 64 |
hsa0502019 | Cervix | CC | Prion disease | 98/1267 | 273/8465 | 2.64e-18 | 1.42e-16 | 8.42e-17 | 98 |
hsa05415110 | Cervix | CC | Diabetic cardiomyopathy | 76/1267 | 203/8465 | 1.40e-15 | 6.46e-14 | 3.82e-14 | 76 |
hsa0501019 | Cervix | CC | Alzheimer disease | 113/1267 | 384/8465 | 9.67e-14 | 3.92e-12 | 2.32e-12 | 113 |
hsa0501619 | Cervix | CC | Huntington disease | 94/1267 | 306/8465 | 8.49e-13 | 3.06e-11 | 1.81e-11 | 94 |
hsa0502219 | Cervix | CC | Pathways of neurodegeneration - multiple diseases | 128/1267 | 476/8465 | 2.87e-12 | 9.29e-11 | 5.50e-11 | 128 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NDUFA12 | insertion | Frame_Shift_Ins | novel | c.8_9insGGGGGAAGACAAATATGGAAACAAATACTATGAAGACAACA | p.Val4GlyfsTer18 | p.V4Gfs*18 | Q9UI09 | protein_coding | TCGA-BH-A0AY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | SD | |||
NDUFA12 | SNV | Missense_Mutation | rs374995908 | c.317N>A | p.Arg106His | p.R106H | Q9UI09 | protein_coding | tolerated(0.2) | benign(0.005) | TCGA-AA-3510-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
NDUFA12 | SNV | Missense_Mutation | c.290C>A | p.Pro97His | p.P97H | Q9UI09 | protein_coding | deleterious(0) | possibly_damaging(0.854) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
NDUFA12 | SNV | Missense_Mutation | c.67N>C | p.Tyr23His | p.Y23H | Q9UI09 | protein_coding | tolerated(0.53) | benign(0.026) | TCGA-G4-6586-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NDUFA12 | SNV | Missense_Mutation | novel | c.286N>T | p.Asp96Tyr | p.D96Y | Q9UI09 | protein_coding | deleterious(0.03) | possibly_damaging(0.873) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
NDUFA12 | SNV | Missense_Mutation | rs766118227 | c.146N>G | p.Tyr49Cys | p.Y49C | Q9UI09 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
NDUFA12 | SNV | Missense_Mutation | novel | c.115N>A | p.Val39Met | p.V39M | Q9UI09 | protein_coding | deleterious(0) | probably_damaging(0.973) | TCGA-PG-A6IB-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
NDUFA12 | insertion | Frame_Shift_Ins | novel | c.332_333insAGAAAAGG | p.Asn112GlufsTer9 | p.N112Efs*9 | Q9UI09 | protein_coding | TCGA-D1-A102-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
NDUFA12 | SNV | Missense_Mutation | c.46N>T | p.Gly16Cys | p.G16C | Q9UI09 | protein_coding | deleterious(0.03) | possibly_damaging(0.855) | TCGA-05-4382-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
NDUFA12 | SNV | Missense_Mutation | c.292N>T | p.Pro98Ser | p.P98S | Q9UI09 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-44-A47A-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
55967 | NDUFA12 | ENZYME | inhibitor | CHEMBL3545135 | NV-128 | |
55967 | NDUFA12 | ENZYME | inhibitor | CHEMBL1703 | METFORMIN HYDROCHLORIDE | |
55967 | NDUFA12 | ENZYME | inhibitor | CHEMBL3545320 | ME-344 |
Page: 1 |